Throughout his 20-year international pharmaceutical career, Albert Kim has held leadership roles across commercial, operation, and finance sectors in Asia-Pacific including South Korea, as well as in Europe, the Middle East and North Africa. He joined Samsung Bioepis in September 2020 as vice president and commercial strategy team leader to head its commercial operations, which covers the global oncology business and immunology businesses outside Europe. Before joining Samsung Bioepis, Kim held several commercial positions, including regional vice-president for Menarini Asia-Pacific region and regional international chief financial officer for Novartis Vaccines.
Kim was chairman of Global Companies CEO Association (GCCA) in South Korea from 2012 to 2016, where he fulfilled his role to represent multinational companies operating in the country and...